Psoriatic arthritis – treating beyond the joint with anti-IL-17 medicines - Certificate of Completion
Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory disease which shares characteristic clinical features, genetic markers and family history with the larger group of seronegative spondyloarthopathies. The diverse clinical picture of PsA, including joint involvement, dactylitis, enthesitis, skin lesions of psoriasis and uveitis, indicates a need to identify suitable therapies to address different combinations of these manifestations.
Fellows of The Royal Australasian College of Physicians (RACP) can claim CPD credits in MyCPD for participation in this course. www.racp.edu.au/mycpd (log in to MyCPD) This interactive online learning activity is valued at 1 Hour(s) of continuing education.
Associate Professor Paul Bird,
BMed (Hons), FRACP, PhD, Grad Dip MRI
St George & Sutherland Clinical School
University of New South Wales
VMO, St George Private Hospital, Kogarah, NSW
Associate Professor Peter A. Foley,
MB BS, BMedSc, MD, FACD
Senior Lecturer in Dermatology
Department of Medicine (Dermatology)
University of Melbourne, St Vincent's Hospital
At the end of this program, participants will be able to:
- Describe the natural history of rheumatoid arthritis (RA) and the criteria for making a diagnosis;
- Identify the risk factors associated with RA and the impact it can have on a person’s home, work and social life;
- Explain emerging models of care in Canada and the key guidelines that impact pharmacist best practices in the management of RA;
- Discuss pharmacologic best practices in the management of RA;
- Communicate non-pharmacologic best practices in the management of RA including common surgical procedures;
- Summarize monitoring strategies and commonly used outcome measures.